Court Rules
All enforcement actions
SettlementCritical RiskMultistate

Attorney General Ellison announces $400 million settlement with Sandoz over conspiracy to inflate drug prices and limit competition

Sandoz Inc.August 4, 2026Connecticut Attorney General

Penalty Amount

$400,000,000

Summary

Minnesota Attorney General Keith Ellison joined a coalition of 43 states and territories in announcing a $400 million settlement in principle with Sandoz Inc. to resolve allegations that the generic drug manufacturer engaged in conspiracies to artificially inflate and manipulate prices, reduce competition, and unreasonably restrain trade for numerous generic prescription drugs. Sandoz will pay approximately $469 million total including prior settlements, and has agreed to injunctive terms and internal reforms.

Remedy

Sandoz Inc. will pay $400 million (approximately $469 million including prior settlements) to resolve antitrust claims. The settlement includes injunctive terms requiring internal reforms to ensure fair competition and compliance with antitrust laws. The settlement is contingent upon signatures from all necessary states and territories.

Monetary PenaltyInjunctionCompliance Program

Contract Impact

In-house legal teams should review vendor and customer agreements for any provisions that could facilitate price fixing, market allocation, or other anticompetitive conduct. This includes clauses related to pricing discussions, information sharing with competitors, and compliance with antitrust laws. They should also ensure that their own compliance programs and internal policies are robust and that contracts include representations and warranties regarding compliance with competition laws. Additionally, review any agreements with distributors, wholesalers, or other partners to ensure no language could be construed as an unreasonable restraint on trade.

Contract Search Terms

antitrust complianceprice fixingcollusionfair competitioncompliance programinternal reformsmarket allocationrestraint of tradegeneric drug pricingcompetition law

Laws Cited

Sherman ActState Antitrust Laws

Violation Types

Entity Details

Entity

Sandoz Inc.

Industry

Healthcare

Multistate Coalition

AlaskaArizonaCaliforniaColoradoConnecticutDelawareDistrict of ColumbiaIdahoIllinoisIndianaIowaKansasKentuckyMaineMarylandMassachusettsMichiganMinnesotaMississippiNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaNorthern Mariana IslandsOhioOklahomaOregonPennsylvaniaPuerto RicoRhode IslandSouth DakotaTennesseeU.S. Virgin IslandsVermontVirginiaWashingtonWest VirginiaWisconsinWyoming

Official Sources

Source Evidence

Entity Name
"Sandoz Inc."
Fine Amount
"$400 million settlement"
Laws Cited
"antitrust laws"
Violation Description
"conspiracy to artificially inflate and manipulate prices, reduce competition, and unreasonably restrain trade"

Related Enforcement Actions

NJ

Sandoz Inc.

$400.0M

Attorney General Jennifer Davenport joined a coalition of 43 states and territories in announcing a $400 million settlement in principle with Sandoz Inc. to resolve allegations of widespread price-fixing and anticompetitive conduct in the generic drug market. Sandoz will pay approximately $469 million total including prior settlements, and has agreed to internal reforms to ensure fair competition.

CT

Sandoz Inc.

$400.0M

Attorney General Tong led a coalition of 43 states and territories in announcing a $400 million settlement in principle with Sandoz Inc. to resolve allegations that the generic drug manufacturer engaged in conspiracies to artificially inflate and manipulate prices, reduce competition, and unreasonably restrain trade. Sandoz will pay approximately $469 million total and implement internal reforms to ensure fair competition and compliance with antitrust laws.

CO

Sandoz Inc.

$400.0M

Attorney General Phil Weiser joined a coalition of 43 states and territories announcing a $400 million settlement in principle with Sandoz Inc. to resolve allegations that the generic drug manufacturer engaged in conspiracies to artificially inflate and manipulate prices, reduce competition, and unreasonably restrain trade. Sandoz will pay approximately $469 million including previous settlements and agreed to meaningful reforms to ensure fair competition and compliance with antitrust laws.

CT

National Highway Traffic Safety Administration

Connecticut Attorney General William Tong joined a coalition of states and local governments in filing suit against NHTSA over its rule weakening fuel economy standards for new passenger cars and light trucks. The lawsuit alleges the rule violates the agency’s statutory mandate and the Administrative Procedure Act; no penalty or final remedy is reported.

CT

U.S. Environmental Protection Agency

Connecticut Attorney General William Tong joined a multistate coalition suing the EPA over its repeal of greenhouse gas pollution limits for power plants and separately filed a notice of intent to sue over regulation of existing gas plants. The coalition asks the court to overturn the repeal and restore the protections; the release reports no monetary penalty or final order.

CT

Sandoz Inc. and Fougera Pharmaceuticals Inc.

$400.0M

Connecticut Attorney General William Tong announced a $400 million settlement with Sandoz Inc. and Fougera Pharmaceuticals Inc. resolving allegations that the generic drug manufacturers conspired to inflate prices, limit competition, and restrain trade. The settlement includes consumer restitution and injunctive reforms; court approval was being sought.